Compare RUN & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RUN | OPCH |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Nursing Services |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.5B |
| IPO Year | 2015 | 1996 |
| Metric | RUN | OPCH |
|---|---|---|
| Price | $13.44 | $20.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 7 |
| Target Price | $18.80 | ★ $36.57 |
| AVG Volume (30 Days) | ★ 10.6M | 2.9M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 113.35 | 3.25 |
| EPS | ★ 0.62 | 0.29 |
| Revenue | $858,578,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | $2.81 | $7.21 |
| Revenue Next Year | $4.54 | $8.55 |
| P/E Ratio | ★ $21.74 | $73.55 |
| Revenue Growth | 12.97 | ★ 16.17 |
| 52 Week Low | $8.97 | $18.01 |
| 52 Week High | $22.44 | $36.80 |
| Indicator | RUN | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 49.38 | 44.65 |
| Support Level | $11.81 | $19.61 |
| Resistance Level | $13.57 | $22.25 |
| Average True Range (ATR) | 1.00 | 0.72 |
| MACD | 0.06 | 0.10 |
| Stochastic Oscillator | 34.87 | 21.31 |
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.